Is too much vitamin C hard on your kidneys?

Vitamin C leaves your body through your kidneys, which is exactly why the question is worth asking.

For most healthy adults the answer is reassuring: intake below the 2,000 mg daily upper limit does not have toxic effects. The risk sits somewhere more specific than "too much".

In an analysis covering 6,245 incident kidney stones, men taking 1,000 mg or more a day had a 43% higher risk of stones. Women showed no increase. Vitamin C from food showed none in either sex.

Table of Contents

• 1. The Short Answer: Dose, Source, and Your Starting Point
• 2. Why Vitamin C and Kidneys Are Connected At All
• 3. What the Large Studies Found — Including a Sex Difference
• 4. When Vitamin C Does Injure Kidneys
• 5. Does Liposomal Vitamin C Change the Kidney Picture?
• 6. Who Should Be Careful
• 7. How to Supplement With Your Kidneys in Mind
• Bio Absorb Liposomal Vitamin C — What We Do and Don't Claim
• Frequently Asked Questions
• Conclusion
• Research References

1. The Short Answer: Dose, Source, and Your Starting Point

"Too much" is doing a lot of work in this question. The tolerable upper intake level for adults is 2,000 mg a day, and the standard clinical reference is blunt about what sits underneath it: intake below the upper limit does not have toxic effects in healthy adults. That covers the range most everyday supplements sit in.

Three things change the answer. The first is dose: risk signals appear at 1,000 mg a day and climb from there. The second is source — in the cohort data, vitamin C from food was not associated with stones in men or women, while supplemental intake was, in men. The third is who you already are, which turns out to matter more than the other two combined.

It is also worth separating two different worries that get muddled together. Kidney stones are painful, common and strongly linked to vitamin C supplements in some people. Kidney damage — scarring, lost function, dialysis — is a different outcome, and it is genuinely rare. Our guide to vitamin C side effects and the upper limit covers the wider safety picture.

2. Why Vitamin C and Kidneys Are Connected At All

Vitamin C is water-soluble and cleared renally, and a fraction of it is metabolised into oxalate before it leaves. Oxalate binds calcium in urine to form calcium oxalate crystals — the most common kidney stone type. That is the entire mechanism, and it is why the conversation exists.

The effect is measurable and dose-dependent. A daily 1,000 mg dose can increase oxalate excretion by 6 to 13 mg a day, and in stone formers given that dose, 24-hour urinary oxalate rose from 31 mg to 50 mg. A 2026 meta-analysis of 9 interventional studies put the pooled increase at 6.45 mg per 24 hours versus placebo, in people with and without a stone history.

Note what this does and does not prove. Raised urinary oxalate is a risk marker, not a stone. Most people with slightly higher oxalate never form one. The authors of that meta-analysis hedge carefully, saying the rise may contribute to stone formation — which is the appropriate strength of claim here.

3. What the Large Studies Found — Including a Sex Difference

The most informative study pooled three large cohorts and followed participants for a median of 11.3 to 11.7 years, identifying 6,245 incident kidney stones. Among men, total vitamin C intake of 1,000 mg a day or more carried a hazard ratio of 1.43 (95% CI 1.15–1.79) against a reference of under 90 mg. Supplemental intake at that level gave a hazard ratio of 1.19 (95% CI 1.01–1.40).

Among women, neither total nor supplemental vitamin C was significantly associated with stones at any intake level. This is a real and under-reported asymmetry, and it is the reason blanket warnings aimed at everyone overstate the case for roughly half the population. The authors state the conclusion plainly: the association held in men, but not in women.

An earlier prospective study of 23,355 Swedish men followed for 11 years found that those taking vitamin C–only supplements had about twice the risk of kidney stones, while multivitamin users showed no increase at all. Three caveats travel with all of this:

• These are observational cohorts. They show association, not causation.
• The Swedish cohort enrolled men only, so it cannot speak to the sex difference either way.
• Food-source vitamin C was not associated with stones in either sex, though few participants ate more than 700 mg a day from food.

4. When Vitamin C Does Injure Kidneys

Beyond stones sits a rarer condition called oxalate nephropathy, where calcium oxalate crystals deposit in the kidney tubules themselves. It is uncommon: as of 2023, 21 cases of acute kidney injury from toxic vitamin C doses had been reported in the published literature. In a review of 100 renal biopsies, oxalate nephropathy accounted for 2.1% of acute kidney injury in elderly patients.

The reported doses are mostly far above anything a normal supplement delivers. One patient developed acute renal failure after taking more than 4 g daily for 30 consecutive days as an alternative cancer treatment. Two critically ill patients received over 100 g intravenously across a few days before biopsy-confirmed oxalate nephropathy appeared.

One case does complicate the reassuring picture, and it belongs here rather than buried. A patient who had taken 2 g a day for more than 30 years — at the upper limit, not above it — developed oxalate nephropathy requiring haemodialysis. That patient also had established diabetic kidney disease, which is the pattern worth noticing: the serious cases cluster in people whose kidneys were already compromised. For the wider dosing question, see our guide to high-dose vitamin C and megadosing.

5. Does Liposomal Vitamin C Change the Kidney Picture?

This is where honesty serves readers better than marketing does. Liposomal delivery demonstrably raises blood levels: a 2025 scoping review screened 321 studies, included 10, and found 9 showed higher bioavailability, with peak concentrations 1.2 to 5.4 times higher and AUC 1.3 to 7.2 times higher than standard vitamin C. Our comparison of why most of a standard vitamin C dose is wasted covers that mechanism in full.

But the kidney question asks about the other end of the journey, and that end has not been studied. The same review states that no trial assessed elimination, and that it is uncertain whether the ratio of liposomal to non-liposomal ascorbate in urine matches the ratio seen in plasma. Nobody has measured urinary oxalate after liposomal vitamin C specifically. That is a gap, not a clean bill of health.

Regulators have flagged the same logic. The UK Committee on Toxicity's 2025 review called the toxicological effects of these novel formulations uncertain and of potential concern, and raised the question of whether safety limits set for a standard form still apply to one built to absorb better. Read conservatively, that points one way: better absorption is a reason to respect the 2,000 mg ceiling more carefully, not less. The side effects of liposomal vitamin C follow the same pattern.

6. Who Should Be Careful

The evidence points consistently at pre-existing conditions rather than at the general population. The groups below have a documented reason to talk to a doctor before taking vitamin C at 1,000 mg a day or more, and the serious case reports overwhelmingly come from inside them rather than outside.

• Anyone who has formed a kidney stone. The 2026 meta-analysis found the oxalate rise in stone formers and non-formers alike, but the consequences differ sharply between the two.
• People with chronic kidney disease or on dialysis. Vitamin C is primarily cleared by the kidneys, so reduced clearance changes the whole calculation. Doses here are a clinical decision, not a consumer one.
• Men taking 1,000 mg or more daily. This is where the hazard ratio of 1.43 was measured, and it is the one group where sex appears to matter.
• People with diabetes, dehydration, malabsorption, or who are older. These recur across the oxalate nephropathy case reports as aggravating factors.

One review puts the advice plainly: stone-forming patients, particularly men, are told to avoid vitamin C supplements at 1,000 mg a day or more. If you are in any group above and want to supplement anyway, that is the conversation to have first. Vitamin C also interacts with a number of medications — see vitamin C interactions with medications and supplements.

7. How to Supplement With Your Kidneys in Mind

None of this argues for avoiding vitamin C. It argues for choosing a dose on purpose rather than by habit, and for recognising that the 2,000 mg ceiling is a limit rather than a target.

• Treat 2,000 mg a day as the ceiling for all sources combined — food, drinks and supplements together, not supplements alone.
• Stay at or below 1,000 mg a day unless you have a specific reason not to. That is where the measurable risk signal begins in men, and where oxalate excretion starts climbing.
• Split larger doses rather than taking them at once. Absorption falls below 50% above 1 gram a day, and what is not absorbed passes through the gut instead.
• Drink enough water. Dilute urine is the single most reliable defence against stone formation, and it costs nothing.
• Get what you can from food. Dietary vitamin C was not associated with stones in either sex in the cohort data.

If you already know your kidneys are not working normally, none of these substitute for a conversation with the person managing your care.

Bio Absorb Liposomal Vitamin C — What We Do and Don't Claim

Bio Absorb Nutraceuticals sells liposomal vitamin C in two formats: Liposomal Vitamin C Liquid 1000mg (Corn-Free) and Liposomal Vitamin C Capsules 1000mg (Corn-Free). The liquid mixes with water or juice; the capsules need no refrigeration and travel well. Both share the same allergen profile — verified corn-free, non-GMO, gluten-free, nut-free, dairy-free and vegan — and both are made in a GMP-certified Canadian facility and third-party tested every batch.

What we will not tell you is that a better-absorbed vitamin C is gentler on your kidneys. Nobody has measured that, and the honest position is to say so. The absorption advantage of liposomal delivery is well supported; its effect on urinary oxalate is simply unstudied, and we are not going to fill that gap with an inference that happens to suit us.

What the format does change is that you can reach a useful blood level without pushing the total dose upward — which, given everything above, is the direction that actually matters for kidneys. The 2,000 mg upper limit applies to our products exactly as it applies to every other form of vitamin C.

Bio Absorb's Liposomal Vitamin C is available in a liquid and a capsule format, both verified corn-free and third-party tested every batch. See current pricing and serving details for the liquid, or the full product specification for the capsules.

Frequently Asked Questions

Does too much vitamin C cause kidney stones?

In men, high supplemental intake is associated with more stones: 1,000 mg a day or more carried a hazard ratio of 1.43 for incident stones. In women, no significant association was found at any intake level. Vitamin C from food was not associated with stones in either sex.

Is 1,000 mg of vitamin C a day safe for your kidneys?

For healthy adults it sits well under the 2,000 mg upper limit, and intake below that limit has no toxic effect in healthy adults. But 1,000 mg is also the dose at which oxalate excretion rises by 6 to 13 mg a day, so if you form stones or have reduced kidney function it is worth discussing with a doctor.

Does liposomal vitamin C increase kidney stone risk?

Nobody knows, and any brand telling you otherwise is guessing. The 2025 scoping review that established the absorption advantage explicitly notes that no trial assessed elimination, and that urine ratios may not mirror plasma ratios. The sensible approach is to treat the 2,000 mg ceiling as applying equally to every form.

Can vitamin C damage healthy kidneys?

It is rare. As of 2023, only 21 cases of acute kidney injury from toxic vitamin C doses had been published, and most involved grams per day over extended periods, intravenous dosing, or kidneys that were already compromised. Standard supplement doses in healthy adults are not where this happens.

Should I take vitamin C if I have chronic kidney disease?

That is a decision for your nephrologist, not a blog. Vitamin C is primarily cleared by the kidneys, and reduced clearance changes both how much accumulates and how much oxalate your kidneys must handle. Low plasma vitamin C is also common across the CKD spectrum, so the answer is genuinely individual.

Is vitamin C from food safer than supplements for kidneys?

The evidence points that way. In the cohort analysis, dietary vitamin C was not associated with stones in men or women, while supplemental intake was in men. One caveat the authors raise: few participants consumed more than 700 mg a day from food, so very high dietary intakes were not well represented.

Conclusion

For a healthy adult staying under 2,000 mg a day, vitamin C is not hard on your kidneys — the evidence is reasonably clear on that. The caution belongs to a narrower group: men at 1,000 mg or more, anyone who has formed a stone, and anyone whose kidneys are already impaired, where a hazard ratio of 1.43 and a handful of serious case reports deserve real weight. If you choose a liposomal form, choose it to use a sensible dose well, not to justify a larger one — see current pricing and serving details.

Research References

1. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. American Journal of Kidney Diseases, Vol. 67, Issue 3 (2016). Followed participants for a median of 11.3–11.7 years across 6,245 incident stones; total intake ≥1,000 mg/day carried a hazard ratio of 1.43 in men, with no significant association in women and none for dietary vitamin C in either sex.
2. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, e70067 (2025). Screened 321 studies and included 10; 9 showed higher bioavailability, with Cmax 1.2–5.4× and AUC 1.3–7.2× higher. Notes that no trial assessed elimination and that urine ratios may not mirror plasma ratios.
3. Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study. JAMA Internal Medicine, Vol. 173, Issue 5 (2013). Followed 23,355 Swedish men for 11 years; vitamin C–only supplement users had roughly twice the stone risk, while multivitamin users showed no increase.
4. The Effect of Vitamin C Supplements on Urinary Stone Risk: A Systematic Review and Meta-Analysis. Journal of Endourology (2026, published online ahead of print). Pooled 9 interventional studies; vitamin C raised urinary oxalate by 6.45 mg per 24 hours versus placebo, in both stone formers and non-formers.
5. Megadose Vitamin C Prescription Through Alternative Medicine Leading to End-Stage Renal Disease: Case Study and Literature Review. Journal of Investigative Medicine High Impact Case Reports, Vol. 11 (2023). Reports that, as of 2023, 21 cases of acute kidney injury from toxic vitamin C doses had been published.
6. Vitamin C–Induced Oxalate Nephropathy: An Underappreciated Consequence of Dietary Supplements. Annals of Internal Medicine: Clinical Cases, Vol. 3, e240370 (2024). Describes oxalate nephropathy requiring haemodialysis in a patient who took 2 g/day for more than 30 years alongside established diabetic kidney disease.
7. Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19. Kidney International Reports, Vol. 5, Issue 10 (2020), pp. 1815–1822. Reports that 1,000 mg/day can increase oxalate excretion by 6–13 mg/day, and documents biopsy-confirmed oxalate nephropathy after intravenous loads exceeding 100 g.
8. Acute oxalate nephropathy induced by oral high-dose vitamin C alternative treatment. Clinical Kidney Journal, Vol. 7, Issue 2 (2014). Documents acute renal failure with extensive tubular calcium oxalate deposition after more than 4 g daily for 30 consecutive days.
9. Vitamin C-induced oxalate nephropathy: a case report. Journal of Community Hospital Internal Medicine Perspectives, Vol. 2, Issue 2 (2012). Reports that oxalate nephropathy accounted for 2.1% of acute kidney injury in elderly patients across a review of 100 renal biopsies.
10. Vitamin C and Benzoic Acid Intake in Patients with Kidney Disease: Is There Risk of Benzene Exposure? Nutrients, Vol. 18, Issue 1, article 132 (2026). Narrative review confirming vitamin C is primarily cleared by the kidneys and that low plasma vitamin C is observed across the chronic kidney disease spectrum.
11. What Stone-formers Should Know About Vitamin C and D Supplementation in the COVID-19 Era. European Urology Open Science, Vol. 21 (2020), pp. 9–11. Reports that stone formers treated with 1,000 mg/day had 24-hour urinary oxalate rise from 31 mg to 50 mg, and recommends advising stone-forming patients, particularly men, to avoid vitamin C supplementation at doses of 1,000 mg/day or more.
12. Vitamin C Toxicity. MSD Manuals Professional Edition (2026). States that the upper limit for vitamin C is 2,000 mg/day, that intake below the upper limit does not have toxic effects in healthy adults, and that high doses may cause hyperoxaluria contributing to calcium oxalate stones.
13. Novel formulations of supplement compounds designed to increase oral bioavailability. UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2025). Describes the toxicological effects of novel high-bioavailability formulations as uncertain and of potential concern, and raises whether health-based guidance values set for standard forms transfer to them.
14. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (2025). States that absorption falls to less than 50% at doses above 1 gram a day, and that unabsorbed vitamin C passing through the intestine causes the common gastrointestinal effects of high intakes.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.